1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MSK-LYMPHOCLONE: Data analysis pipeline and tools for immune repertoire analysis
    Meeting Abstract

    Syed, M. H.; Khedoudja, N.; Baldi, T.; Zehir, A.; Cheng, D.; Ladanyi, M.; Arcila, M. E.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Evaluation of microsatellite instability detection by the MSK-IMPACT 410 gene hybrid-capture, NGS-based platform
    Meeting Abstract

    Middha, S.; Hechtman, J.; Shia, J.; Zarina, Y.; Berger, M.; Nafa, K.; Zhang, L.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Comparison of molecular typing methods and the Xpert C. difficile/Epi assay for the Identification of Clostridium difficile North American pulse-field type 1 (NAP-1)
    Meeting Abstract

    McMillen, T.; Kamboj, M.; Babady, N.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Benefits and challenges of next generation sequencing in routine assessment of myeloid neoplasms: MSKCC two-year experience
    Meeting Abstract

    Middha, S.; Zaidinski, M.; Son, J.; Mohanty, A.; Zehir, A.; Cheng, D.; Nafa, K.; Benayed, R.; Jour, G.; Tian, S.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Validation and clinical implementation of next-generation sequencing for routine IGH and TCRG clonality assessment
    Meeting Abstract

    Arcila, M. E.; Baldi, T.; Syed, M.; Rijo, I.; Bakas, J.; Momin, Z.; Ladanyi, M.; Nafa, K.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Spectrum of JAK2 positive myeloid neoplasms: Beyond MPN
    Meeting Abstract

    Yao, J.; Mohanty, A. S.; Getta, B. M.; Rampal, R. K.; Arcila, M. E.
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Clinical monitoring of patients with myeloid malignancies using targeted next-generation sequencing
    Meeting Abstract

    Mohanty, A.; Zaidinski, M.; Son, J.; Zehir, A.; Middha, S.; Cheng, D. T.; Jour, G.; Tian, S. K.; DeLair, D.; Sadri, N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Targeted sequencing analysis of commonly mutated genes in chronic myelomonocytic leukemia using NGS: Impact and clinical implications
    Meeting Abstract

    Valencia, A.; Abdel-Wahab, O.; Buchi, F.; Masala, E.; Sanna, A.; Gozzini, A.; Figueroa, M. E.; Contini, E.; Torricelli, F.; Allione, B.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Outcomes of anticoagulant or antiplatelet use in patients with chronic lymphocytic leukemia or indolent non-Hodgkin's lymphoma in idelalisib trials
    Meeting Abstract

    Ghia, P.; Carella, A. M.; Massaia, M.; Barrientos, J.; Pagel, J.; Salles, G.; Sharman, J. P.; Stilgenbauer, S.; Gurtovaya, O.; Kim, Y.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Improved survival in patients ≥60 with first relapsed/refractory acute myeloid leukemia treated with vosaroxin plus cytarabine vs placebo plus cytarabine: Results from the phase 3 VALOR study
    Meeting Abstract

    Carella, A. M.; Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; more...
    Haematologica (2015)

    Fulltext@MSK | Save